Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor
Melanoma is a deadly disease at late metastatic stage, and early diagnosis and accurate staging remain the key aspects for managing melanoma. The melanocortin 1 receptor (MC1 R) is overexpressed in primary and metastatic melanomas, and its endogenous ligand, the α-melanocyte-stimulating hormone (αMS...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-11-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.1177/1536012117737919 |